Advance Research

Advance Research

We are working to drive research to better treatments, and ultimately a cure, as quickly as possible

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $30 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.

From the Blog

  1. October 30, 2014

    Creating Meaningful Change, With a Little Help From our Friends

    There are only four FDA-approved therapies to treat brain tumors. And in the last 17 years there have been approximately 75 potential new drugs that have failed during the clinical trial process to prove they are safe and effective for patients, while only three that have won FDA approval[1]. That is a 25:1 failure ratio. […]

    Creating Meaningful Change, With a Little Help From our Friends Read more | 
  2. October 28, 2014

    A New “America’s Neuro-Oncologist” at the National Cancer Institute

    Yesterday, it was announced that Dr. Mark R. Gilbert, MD, has been named Chief of the Neuro-Oncology Branch (NOB) at the National Institutes of Health (NIH), within the Center for Cancer Research of the National Cancer Institute (NCI). In this position, Dr. Gilbert – previously Deputy Chairman of the Department of Neuro-Oncology at MD Anderson […]

    A New “America’s Neuro-Oncologist” at the National Cancer Institute Read more | 
  3. October 22, 2014

    Hope for GBM Patients

    Recent news and conversations across social media has churned up a lot of concern and fear over glioblastoma multiforme (GBM) tumors. And while we know all too well it’s the deadliest form of brain cancer with dismal survival rates, we also want the public to know how the National Brain Tumor Society is working to […]

    Hope for GBM Patients Read more | 
More from the blog